TOIIW · Starling Oncology, Inc.

Summary

The Oncology Institute, Inc. furnished an Investor Presentation dated March 13, 2026, as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This presentation provides investor-focused information.

Key takeaways

• Investor Presentation furnished as Exhibit 99.1.
• Dated March 13, 2026.
• Filed under Item 7.01.
• Not deemed 'filed' under Section 18 of the Exchange Act.